Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

MabVax Therapeutics Holdings, Inc.

TRADE

NASDAQ: MBVXHealthcare / Biotechnology / USA
0.40-0.06-13.02%Vol 8 9741Y Perf -81.48%
Sep 25th, 2018 15:57
BID0.00 ASK0.00
Open0.445 Previous Close0.46
Pre-Market- After-Trading-
 - -%  - -%
Target Price
15.00 
Analyst Rating
— 0.00
Potencial %
3 649.06 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/-100 
Income Ranking
 —    -
Market Cap (mil)4 
Earnings Rating
Neutral
Price Range Ratio 52wk %
4.65 
Earnings Date
1st Oct 2018

Today's Price Range

0.400.455

 

52wk Range

0.263.27

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-24.51%
3 Months
-56.98%
6 Months
-76.60%
1 Year
-81.48%
3 Years
-95.99%
5 Years
-99.41%

Quotes

Name / TickerPriceChg.Chg.%
MBVX0.40-0.0599-13.02
AAPL222.191.40000.63
GOOG1 184.6511.28000.96
MSFT114.45-0.2200-0.19
XOM86.50-0.1000-0.12
WFC54.23-0.0300-0.06
JNJ138.64-1.8300-1.30
FB164.91-0.5000-0.30
GE11.27-0.4700-4.00
JPM116.39-0.3300-0.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.20
Current Ratio 0.20
Long Term Debt to Total Capital 0.60
Total Debt to Equity 3.01
Interest Coverage -81.20
Leverage Ratio 7.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-2 763.70
EBITDA Margin-2 745.00
Pre-tax Profit Margin-5 782.00
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.64
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.80
Cash Flow Per Share -2.87
Price to Tangible Book-0.71
Book Value per Share0.13
Enterprise Value (in ths.)6 569
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)19 579.40
ROE last 12 Months -1 472.22
Return on Assets (5Y Avg) -199.53
ROA last 12 Months -315.14
Return on Capital (5Y Avg) -642.29
ROC last 12 Months -303.10
Return on invested Capital Q -187.08
Return on invested Capital Y-534.45
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2017--1.62-
Q02 2017--4.41-
Q01 2017--2.55-
Q03 2016-2.22-2.58-16.22
Q02 2016-1.41-0.8936.88
Q01 2016-1.18-1.115.93
Q02 2015-0.89-2.15-141.57
Q01 2015--6.25-
Earnings Per EndEstimateRevision %Trend
12/2016 QR-0.690.00-
12/2017 FY-3.010.00-
12/2018 FY-2.930.00-
----
Next Report Date1st Oct 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume8 974
Shares Outstanding (in ths.)8 960
Trades Count8
Dollar Volume3 788
Avg. Volume241 040
Avg. Weekly Volume19 855
Avg. Monthly Volume18 634
Avg. Quarterly Volume478 412

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

69%31%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x